A carregar...
Mendelian Randomization Studies Promise to Shorten the Journey to FDA Approval
There has been a dearth of new drugs approved for cardiovascular disorders. The cost is prohibitive, averaging to $2.5 billion, and requiring 12.5 years. This is in large part due to the high failure rate, with only 5% approval by the Food and Drug Administration. Despite preclinical studies showing...
Na minha lista:
| Publicado no: | JACC Basic Transl Sci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6234613/ https://ncbi.nlm.nih.gov/pubmed/30456340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacbts.2018.08.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|